For example, increased expression of CXCL5 in the tumor microenvironment has been linked to activation of the CXCR2 pathway and recruitment of pro-tumor immune cells, thereby promoting tumorigenesis and angiogenesis, demonstrating that CXCL5 expression drives glioblastoma progression [62]. Here, CXCR2 is linked to glioblastoma.